MYB and ovarian carcinoma: LOC102724169 suppresses the expression of MYB in ovarian cancer with chronic stress (OCCS) by weakening PI3K/Akt signal transduction, which enhances the chemosensitivity to cisplatin and plays an antitumor role in OCCS [84].